Probiotic beverage with soy isoflavone consumption for breast cancer prevention: a case-control study

…, A Tomotaki, N Sato, Y Hozumi, K Anan… - Current Nutrition & …, 2013 - ingentaconnect.com
The purpose of this study is to evaluate how beverages containing Lactobacillus casei Shirota
(BLS) and soy isoflavone consumption since adolescence affected the incidence of breast …

Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer

K Anan, T Morisaki, M Katano, A Ikubo, H Kitsuki… - Surgery, 1996 - Elsevier
Background. Angiogenesis is a prerequisite for tumor growth and metastasis. Tumor angiogenesis
may be mediated by several angiogenic factors such as vascular endothelial growth …

[HTML][HTML] Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer …

…, H Miyata, N Niikura, M Kawai, K Anan… - Breast cancer research …, 2016 - Springer
Purpose The aim of this study was to investigate whether young age at onset of breast cancer
is an independent prognostic factor in patients from the Japanese Breast Cancer Registry, …

Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry

…, H Miyata, T Iwamoto, N Niikura, K Anan… - Cancer …, 2016 - Wiley Online Library
Few studies have reported the association between body mass index ( BMI ) and outcome
among Asian breast cancer patients. We analyzed data for 20,090 female invasive breast …

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer

N Masuda, H Iwata, Y Rai, K Anan, T Takeuchi… - Breast cancer research …, 2011 - Springer
This study compared the efficacy and safety of a 3-monthly 10.8-mg depot goserelin (Zoladex
TM ) injection with the current 3.6 mg monthly dose in pre-menopausal Japanese women …

[HTML][HTML] Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen …

R Nishimura, K Anan, Y Yamamoto… - Oncology …, 2013 - spandidos-publications.com
The aim of the present study was to assess the efficacy and tolerability of a luteinizing
hormone-releasing hormone (LH-RH) analogue plus an aromatase inhibitor following failure to …

Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy

Y Watanabe, K Anan, M Saimura, K Koga, M Fujino… - Breast Cancer, 2018 - Springer
Background The aim of this study was to investigate preoperative factors associated with
ductal carcinoma in situ (DCIS) upstaged to invasive ductal carcinoma (IDC) and sentinel …

Immunosuppressive cytokines (IL‐10, TGF‐β) genes expression in human gastric carcinoma tissues

T Morisaki, M Katano, A Ikubo, K Anan… - Journal of surgical …, 1996 - Wiley Online Library
Background Contribution of immunosuppressive cytokines to tumor progression in many
types of cancers has been suggested. To characterize the in vivo expression of …

[HTML][HTML] Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

…, K Terata, K Kida, Y Sagara, T Ueno, K Anan… - Breast Cancer Research …, 2023 - Springer
Purpose Mammography screening has increased the detection of subcentimeter breast
cancers. The prognosis for estrogen receptor (ER)-positive and human epidermal growth factor …

Role of postmastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer patients: a study from the Japanese Breast Cancer Registry

…, H Miyata, T Iwamoto, M Kawai, K Anan… - Annals of Surgical …, 2019 - Springer
Background The role of postmastectomy radiotherapy (PMRT) in breast cancer patients
receiving neoadjuvant chemotherapy (NAC) is controversial. We aimed to evaluate the …